Company Filing History:
Years Active: 2021
Title: Shuhhui Chen: Innovator in Hepatitis B Treatment
Introduction
Shuhhui Chen is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of viral hepatitis B. His innovative work has led to the development of a unique compound that shows promise in combating this viral infection.
Latest Patents
Shuhhui Chen holds a patent for a hepatitis B virus surface antigen inhibitor. The patent details the use of 10-oxo-6,1-dihydrobenzo[e]pyrido[1,2-c][1,3]oxazine-9-carboxylic acid derivatives as hepatitis B surface antigen inhibitors or pharmaceutically acceptable salts thereof. This invention outlines the pharmaceutical compositions and methods for preparing medicaments aimed at treating viral hepatitis B.
Career Highlights
Chen is associated with Fujian Cosunter Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating effective treatments for hepatitis B, a condition that affects millions worldwide.
Collaborations
Shuhhui Chen collaborates with notable colleagues, including Fei Sun and Jinhua Du. Their combined expertise enhances the research and development process, leading to innovative solutions in the pharmaceutical industry.
Conclusion
Shuhhui Chen's contributions to hepatitis B treatment exemplify the impact of innovative thinking in medicine. His patent and ongoing work at Fujian Cosunter Pharmaceutical Co., Ltd. highlight the importance of research in developing effective therapies for viral infections.